$TXHD MOMO starting Monday. DD: Emerging Markets

New Post Public Reply Private Reply Replies (0) Message Board
makebucks
$TXHD MOMO starting Monday.

DD:



Emerging Markets Report: The SMS Revolution is Now

Growth, Market and Future of Text Communication is Enormous














Share

2
Print
July 21, 2016 07:01 ET | Source: Emerging Markets LLC


ORLANDO, Fla., July 21, 2016 (GLOBE NEWSWIRE) -- The Emerging Markets Report, by definition, looks for growth opportunities in growth markets. We are constantly looking for market trends that change the way we live and function, that become a part of the core of our society. And we seek businesses that are already penetrating these markets.


It’s not breaking news that texting or “SMS” - Short Message Service - has become a fixture of our existence. And it’s not a trend or a fad. It’s a communication game-changer like mobile phones themselves or the Internet. Indeed, texting is a revolution.

And before that begins to sound like hyperbole, take a look at these statistics:
•Texting is the most used app on smartphones. 97% of Americans text at least once a day. (Source: Pew Internet)
•This year alone people worldwide will send 8.3 trillion text messages. That’s almost 23 billion messages per day, or almost 16 million messages per minute. (Source: Portio Research)
•Over 6 billion text messages are sent in the United States each day. (Source: Forrester)
•Over 80% of American adults text, establishing it as the most common cell phone activity. (Source: Pew Internet)
•Text messages have a 98% open rate. Email averages a 20% open rate. (Source: Mobile Marketing Watch)
•Text messages have a 45% response rate. Email gets just a 6% response rate. (Source: Velocify)
•Most text messages are read in under five seconds. (Source: SlickText)
•On average, Americans exchange twice as many texts as phone calls. (Source: Nielsen)

The numbers are overwhelming, indeed the stuff of revolution, at least in how we communicate. But how do businesses harness this massive communication change, this enhanced way to reach their desired end-user?

Enter Textmunication (OTC:TXHD), a company with a business model which uses SMS communication to improve the way businesses interact with customers in an array of verticals. The Company is already generating revenue and has a presence in the United States and internationally. (Source: http://yhoo.it/29SR4WZ)

Textmunication is focused on creating turn-key solutions for businesses to communicate more effectively with their markets, potentially driving profits while enhancing the customer relationship. Recently, TXHD announced the roll-out of a proprietary API integration platform to allow businesses to pull data from their existing CRM (Customer Relationship Management) software for the purposes of text communication.

This means, for example, that a business with a half-million customers can quickly extract their available text information to send offers and incentives, surveys and other business builders… all through SMS text where the aforementioned data says that that there is a 98% open rate, a 45% response rate, and gets read in under five seconds, generally speaking.

The beneficial impact on a business in undeniable. In fact, for some, it might just be revolutionary.

About Textmunication:

Textmunication (www.textmunication.com) is a SMS/Text marketing solution company focused on businesses with repeat customer interaction such as health and fitness, restaurants and medical care. Textmunication offers SMS/Text messaging exclusively and the Textmunication platform integrates with enterprise software CRM solutions to manage customer accounts.

About the Emerging Markets Report:

Emerging Markets Report is owned and operated by Emerging Markets Consulting, a syndicate of investor relations consultants representing years of experience. Our network consists of stock brokers, investment bankers, fund managers, and institutions that actively seek opportunities in the micro and small-cap equity markets.

For more informative reports such as this, please sign up at http://www.emergingmarketsllc.com/newsletter.php

Section 17(b) of the Securities Act of 1933 requires that any person that uses the mails to publish, give publicity to, or circulate any publication or communication that describes a security in return for consideration received or to be received directly or indirectly from an issuer, underwriter, or dealer, must fully disclose the type of consideration (i.e. cash, free trading stock, restricted stock, stock options, stock warrants) and the specific amount of the consideration. In connection therewith, EMC has received the following compensation and/or has an agreement to receive in the future certain compensation, as described below.

We may purchase Securities of the Profiled Company prior to their securities becoming publicly traded, which we may later sell publicly before, during or after our dissemination of the Information, and make profits therefrom.

EMC has been paid 6,500,000 restricted shares by Textmunication.

Emerging Markets Consulting, LLC

Florida Office

15701 State Road 50, Suite #205

Clermont, FL 34711

E-mail: jamespainter@emergingmarketsllc.com
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Spooky Dining at CARNE: A Halloween Hit in Oxnard

Updated Category News Views 221

A Festive Transformation at CARNE Rolling into Oxnard, you're met with an unconventional dining spectacle at CARNE. It's not your average restaurant fare as they've pulled out the stops with their spirited Halloween pop-up, A Nightmare at CARNE. Channeling the eerie charm of "The Nightmare Before Christmas," this temporary transformation morphs the venue into a lively,...

Continue Reading
Bio-Thera's New Data: A Game Changer for NSCLC?

Updated Category News Views 378

A Fresh Look at Lung Cancer Solutions There's fresh meat on the oncology block, with Bio-Thera Solutions swinging for the fences at ESMO 2026, spotlighting promising Phase 2 clinical data for their combo treatment in first-line non-small cell lung cancer (NSCLC). If you're tuned into the biopharmaceutical sector or just keeping tabs on global health romps, this news sets...

Continue Reading
Alaska's Insurance Maze: Coverage Over Cheap Policies

Updated Category News Views 171

Beyond Premiums: Assessing Real Coverage Needs The Alaskan wilderness isn't just home to stunning views; it's also a land where insurance needs to go beyond the average cookie-cutter policy. You'd think the cheapest option would suffice, but that's where residents might trip into financial quicksand. Devery Prince, a seasoned insurance principal, sheds light on why...

Continue Reading
Innovent's IBI3001 Shows Promise in Phase 1 Trials

Updated Category News Views 139

Pioneering Path with IBI3001 at ESMO 2026 Navigating through the crowded landscape of oncology trials, Innovent Biologics recently rolled out some riveting Phase 1 clinical data for their new darling, IBI3001. Top brass from Innovent took to the European Society for Medical Oncology (ESMO) Congress stage to lay bare their findings. Obviously, when you're presenting a...

Continue Reading
ST Engineering iDirect, MBSat Forge Middle East Satellite Hub

Updated Category News Views 118

Satellite Services Take Off in the Middle East Never thought the day would come where the Middle East is on the threshold of leapfrogging satellite tech, but here we are. ST Engineering iDirect just locked arms with MBSat—yep, that's part of the Mohammed Al Barwani Group—to birth a next-gen satellite connectivity service hub in Oman and across surrounding areas....

Continue Reading
Johnson & Johnson's JNJ-6143 Shines in Prostate Cancer Study

Updated Category News Views 145

Prostate Cancer's Persistent Challenge No one in the healthcare game needs the reminder: prostate cancer is no walk in the park, especially for those grappling with advanced stages. Now picture this—you're on your sixth treatment, and the cloud is not lifting. It's a battle that never ends, with traditional therapies sometimes barely holding the line. JNJ-6143's New...

Continue Reading
Lilly's Olomorasib: New Data Sparks Hope for G12C NSCLC

Updated Category News Views 35

New Data Unveiling Potential Shifts in NSCLC Treatment Man, if there's one thing the oncology world craved, it's progress against KRAS G12C-mutant non-small cell lung cancer (NSCLC). We're talking about a challenge as tough as a two-dollar steak. But hey, Eli Lilly's (NYSE:LLY) putting some serious cards on the table with olomorasib, and folks at the ESMO 2026 Congress...

Continue Reading
CSTS Unveils PremierX in NYC: A Bold Entertainment Move

Updated Category News Views 228

Welcome to the New Era of Entertainment Out of the blockbusters and into the open air, eh? On October 30, 2026, CSTS Enterprises flipped the New York skyline into a canvas for their grand kickoff of PremierXTM—a live entertainment brand poised to redefine how we gobble up our music, sport, and art. Now, there's a shot of adrenaline New Yorkers weren't exactly begging...

Continue Reading
Master Sommeliers and Italian Producers Clash on Wine Lists

Updated Category News Views 166

Wines Jockeying for New York’s Coveted Lists Alright, picture a stage set up in New York City like an arena. But instead of gladiators, you've got master sommeliers on one side and Italian wine producers on the other, each armed with their own arguments. They're locked in a battle over what it really takes to get a bottle imbedded on a New York City's prestigious wine...

Continue Reading
What to Expect: Your First Therapy Session Insights

Updated Category News Views 201

Starting With the Unknown: The Therapy Journey Begins Rolling into that first therapy session can feel like walking into a mystery with no clues. You're not alone if it stirs up some nerves—most folks feel the same, especially when it's your first rodeo in mental health support. That's where Cody Luke and David Spencer of Luke and Spencer Behavioral Health, based out in...

Continue Reading

Top 5 Most Recently Viewed Articles

Exploring Opportunities in Oversold Tech Stocks Today

Updated Category News Views 121

Market Dynamics and Oversold Stocks Recently, we witnessed a notable sell-off in the stock market, which was fueled by rising concerns surrounding the AI industry. As a result, many stocks experienced a significant pullback. Interestingly, this downturn did not discriminate and impacted various equities, including those unrelated to the AI sector. It's essential to...

Continue Reading
Innovative Device Revolutionizes Leg Recovery Process

Updated Category News Views 109

A Breakthrough in Leg Recovery: The LEG LIFTER Recovering from an injury or surgery can be a challenging process, especially when it comes to managing mobility. An inventive entrepreneur has come up with a unique solution to assist those dealing with leg injuries. The designer, based in Marietta, has developed the LEG LIFTER, a tool aimed at facilitating the lifting and...

Continue Reading
Vizsla Silver's New Strategic Acquisition Enhances Panuco Project

Updated Category News Views 78

Vizsla Silver Expands its Footprint with Key Acquisition In an exciting development, Vizsla Silver Corp. (NYSE: VZLA) (TSX: VZLA) has entered into an agreement to acquire significant claims that will bolster its already promising Panuco project. Ten new claims totaling 2,378 hectares have been purchased from Minera Fresnillo S.A. de C.V., a Fresnillo plc subsidiary. This...

Continue Reading
C3.ai Investors Seek Justice Amid Recent Stock Concerns

Updated Category News Views 91

Understanding the Situation for C3.ai Investors C3.ai, Inc. (NYSE: AI) has recently made headlines, not for positive advancements, but due to significant concerns regarding its stock performance and allegations of misleading statements. Shareholders who purchased shares during a specific class period might have encountered substantial losses, prompting the need for...

Continue Reading
Class Action Alert for Investors of Regeneron Pharmaceuticals

Updated Category News Views 139

Investors of Regeneron Pharmaceuticals Urged to Act In the bustling world of biotechnology, Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) has captured significant attention. Recently, the exceptionally reputable Rosen Law Firm announced a class action lawsuit, bringing notice to shareholders who have purchased securities from November 2, 2023, to October 30, 2024. This...

Continue Reading